>
Organization
Alexion Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Alexion Pharmaceuticals, Inc.

... in the life sciences industry, is the Chief Executive Officer of Alexion Pharmaceuticals, Inc., a publicly-traded global biopharmaceutical company. Before joining Alexion, Dr. Hantson was ...
... roles, Ms. O'Neill was formerly Executive Vice President, Global Operations at Alexion Pharmaceuticals, Inc. where, for five years, she led the Global Operations business including ...
... Alexion Pharmaceuticals' ALXN1210 for paroxysmal nocturnal hemoglobinuria (PNH) is unlikely to see a ...
... Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at Credit Suisse's 27th ...
... recently with the initiation of two Phase 1 trials combining ENHANZE with Alexion's ALXN1210 and Bristol-Myers Squibb's BMS-986179, an investigational anti-CD-73 antibody, reinforces our confidence ...
... third quarter of 2018, Xencor received $9 million in milestone payments from Alexion in connection with their submission of marketing authorizations for ALXN1210 to the ...
... hyperoxaluria, our recently announced strategic collaboration and licensing agreements with Lilly and Alexion, and the completion of a $115.0 million follow-on offering. These achievements reflect ...
... to turn off disease-causing genes. On Wednesday, it said that Boston-based Alexion Pharmaceuticals Inc. was paying Dicerna $22 million upfront to help develop two of ...
... Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the previously announced acquisition of Syntimmune has ...
... BOSTON - Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that nine abstracts from its complement research and ...
Subscribe now for full coverage on Alexion Pharmaceuticals, Inc.
Start My Free Trial